# Nuclide record capecitabine (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/capecitabine/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "capecitabine" ;
  schema:name "Capecitabine"@en ;
  schema:description "Capecitabine (Xeloda) is a tablet form of the chemotherapy fluorouracil. It is a backbone of treatment for bowel cancer and a standard option in advanced breast cancer."@en ;
  schema:url <https://nuclide.cc/drugs/capecitabine/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Capecitabine> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=capecitabine>, <https://www.cancer.gov/about-cancer/treatment/drugs/capecitabine>, <https://www.ema.europa.eu/en/medicines/human/EPAR/xeloda> ;
  nuclide:status "approved" ;
  nuclide:tag "nci-list", "generic" ;
  nuclide:modality "Oral fluoropyrimidine prodrug (antimetabolite)" ;
  schema:alternateName "Xeloda" ;
  nuclide:approval "US 1998: Metastatic breast cancer after anthracycline and taxane; later adjuvant and metastatic colorectal cancer, rectal chemoradiotherapy", "EU 2001: Colorectal, gastric and breast cancer" ;
  nuclide:indications <https://nuclide.cc/indications/breast-her2-positive/> ;
  nuclide:trials <https://nuclide.cc/trials/nct06247995/>, <https://nuclide.cc/trials/nct04919226/> .